3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide

C22H17F3N8O7S3 — CID 90056913

IUPAC3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide
SMILESCS(=O)(=O)C(c1nnc(CNS(N)(=O)=O)o1)c1nc2ccc(-c3cccc(C(=O)Nc4nnc(C(F)(F)F)o4)c3)cc2s1
InChIInChI=1S/C22H17F3N8O7S3/c1-42(35,36)16(18-31-30-15(39-18)9-27-43(26,37)38)19-28-13-6-5-11(8-14(13)41-19)10-3-2-4-12(7-10)17(34)29-21-33-32-20(40-21)22(23,24)25/h2-8,16,27H,9H2,1H3,(H2,26,37,38)(H,29,33,34)
InChIKeyROOSQDYZQURAFZ-UHFFFAOYSA-N
MW658.62 g/mol
LogP2.43
Rot. Bonds9

About 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide

3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide (PubChem CID 90056913) has the molecular formula C22H17F3N8O7S3 and a molecular weight of 658.62 g/mol. Its IUPAC name is 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide.

Molecular Properties

Compound Name3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide
PubChem CID90056913
Molecular FormulaC22H17F3N8O7S3
Molecular Weight658.62 g/mol
Exact Mass658.03
IUPAC Name3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide
SMILESCS(=O)(=O)C(c1nnc(CNS(N)(=O)=O)o1)c1nc2ccc(-c3cccc(C(=O)Nc4nnc(C(F)(F)F)o4)c3)cc2s1
InChIInChI=1S/C22H17F3N8O7S3/c1-42(35,36)16(18-31-30-15(39-18)9-27-43(26,37)38)19-28-13-6-5-11(8-14(13)41-19)10-3-2-4-12(7-10)17(34)29-21-33-32-20(40-21)22(23,24)25/h2-8,16,27H,9H2,1H3,(H2,26,37,38)(H,29,33,34)
InChIKeyROOSQDYZQURAFZ-UHFFFAOYSA-N
XLogP2.43
TPSA226.16 Ų
H-Bond Donors3
H-Bond Acceptors13
Rotatable Bonds9
Heavy Atoms43
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500658.62
LogP ≤ 52.43
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1013

Analyze 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide?
The IUPAC name of 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide (CID 90056913) is 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide.
What is the SMILES notation for 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide?
The canonical SMILES for 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide is CS(=O)(=O)C(c1nnc(CNS(N)(=O)=O)o1)c1nc2ccc(-c3cccc(C(=O)Nc4nnc(C(F)(F)F)o4)c3)cc2s1.
What is the InChIKey of 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide?
The InChIKey is ROOSQDYZQURAFZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H17F3N8O7S3/c1-42(35,36)16(18-31-30-15(39-18)9-27-43(26,37)38)19-28-13-6-5-11(8-14(13)41-19)10-3-2-4-12(7-10)17(34)29-21-33-32-20(40-21)22(23,24)25/h2-8,16,27H,9H2,1H3,(H2,26,37,38)(H,29,33,34).
What are the key properties of 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide?
3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide has a molecular weight of 658.62 g/mol, XLogP of 2.43, 9 rotatable bonds, 3 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[2-[methylsulfonyl-[5-[(sulfamoylamino)methyl]-1,3,4-oxadiazol-2-yl]methyl]-1,3-benzothiazol-6-yl]-N-[5-(trifluoromethyl)-1,3,4-oxadiazol-2-yl]benzamide is sourced from PubChem (CID 90056913), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).